Background illustration for clinical trials search

Paid Clinical Trials Orlando

Discover 1,033 paid clinical trials in Orlando, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Celebration FL, Miami FL, Charleston SC, Denver CO,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06253130

Phase 1, Phase 2, Recruiting

Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes

for
Diabetes Mellitus, Type 1, Endothelial Dysfunction
Location: Orlando FL
Sponsor: AdventHealth Translational Research Institute

Sex: All

Age: 18 - 40

Code: NCT05478707

Phase 2, Recruiting

Determining Cell- and Spatially-distinct Skeletal Muscle Transcriptional Aberrations in Insulin Resistance

for
Insulin Resistance
Location: Orlando FL
Sponsor: AdventHealth Translational Research Institute

Sex: All

Age: 30 - 65

Code: NCT07516509

Recruiting

Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis

for
Type 2 Diabetes, Hepatic Steatosis
Location: Orlando FL
Sponsor: AdventHealth Translational Research Institute

Sex: All

Age: 25 - 55

Code: NCT06993454

Recruiting

A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

for
Narcolepsy Type 2
Location: Orlando FL, Brandon FL, Bradenton FL, Jacksonville FL,
Sponsor: Takeda

Sex: All

Age: 18 - 70

Code: NCT06952699

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma
Location: Orlando FL, Weston FL, Hollywood FL, Charleston SC,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT05552222

Phase 3, Recruiting

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

for
Multiple Myeloma
Location: Orlando FL, Tampa FL, Charleston SC, Atlanta GA,
Sponsor: European Myeloma Network B.V.

Sex: All

Age: 18+

Code: NCT05243797

Phase 3, Recruiting

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

for
HIV Infections
Location: Orlando FL, DeLand FL, Tampa FL, Ft. Pierce FL,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07682961

Phase 3, Recruiting

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

for
HIV Infections
Location: Orlando FL, Miami FL, Charleston SC, Pensacola FL,
Sponsor: Gilead Sciences

Sex: All

Age: 18+

Code: NCT07473778

Recruiting

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

for
Lennox Gastaut Syndrome
Location: Orlando FL, Miami FL, Charlotte NC, Morrisville NC,
Sponsor: Epygenix

Sex: All

Age: 2 - 55

Code: NCT05066217

Phase 3, Recruiting

Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics

for
Major Depressive Disorder, Apathy
Location: Orlando FL
Sponsor: AdventHealth

Sex: All

Age: 60+

Code: NCT05877885

Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia,
Location: Orlando FL, Tampa FL, Gainesville FL, Sarasota FL,
Sponsor: United Therapeutics

Sex: All

Age: 18+

Code: NCT06388421

Recruiting

Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Orlando FL, Ocala FL, Gainesville FL, Hollywood FL,
Sponsor: OncoC4, Inc.

Sex: All

Age: 18+

Code: NCT06635785

Phase 1, Phase 2, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Orlando FL, Tampa FL, Jacksonville FL, Miami FL,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase 3, Recruiting

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

for
Solid Tumor, Advanced Solid Tumor, Solid Tumor, Adult,
Location: Orlando FL, Augusta GA, Atlanta GA, Nashville TN,
Sponsor: NiKang Therapeutics, Inc.

Sex: All

Age: 19+

Code: NCT06586957

Phase 1, Recruiting

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

for
Colorectal Neoplasms
Location: Orlando FL, St. Petersburg FL, Fort Myers FL,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06750094

Phase 3, Recruiting

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Orlando FL, Miami FL, Germantown TN, Lexington KY,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06203210

Phase 3, Recruiting

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Orlando FL, Tampa FL, Jacksonville FL, Miami FL,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT06787612

Phase 2, Recruiting

Gut Microbiome and Treatment for Gynecological Cancer Patients Receiving Immunotherapy

for
Gynecologic Cancer, Immunotherapy, Gut Microbiome
Location: Orlando FL
Sponsor: Viome

Sex: Female

Age: 18+

Code: NCT04957511

Recruiting

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

for
Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Location: Orlando FL, Tampa FL, Miami FL, Atlanta GA,
Sponsor: Nuvalent Inc.

Sex: All

Age: 18+

Code: NCT06765109

Phase 3, Recruiting

Orlando, Florida has a well-developed healthcare system with several prominent medical research facilities, making it an important hub for a diverse array of clinical trials. Notable institutions such as the Orlando Health Cancer Institute and the University of Central Florida's College of Medicine are at the forefront of these research initiatives.

Each medical center in Orlando focuses on innovative studies across various fields, including oncology, cardiovascular health, and neurological disorders, positioning Orlando as a vital contributor in advancing medical research and treatment options.

Why choose Orlando for clinical trials?

Orlando offers a vast array of advantages for individuals considering participation in clinical trials. The city is home to a diverse population, which helps create a wide range of participants, enhancing the reliability and applicability of research findings.

Additionally, Orlando’s thriving healthcare ecosystem fosters an environment of innovation and collaboration, with a strong emphasis on advancing medical research and treatment. By participating in a clinical trial in Orlando, participants not only gain access to innovative therapies but also play a crucial role in advancing scientific knowledge.

Common conditions studied in Orlando

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Orlando